Chitogenx Stock Return On Equity
| CHNXF Stock | USD 0.01 0.00 0.00% |
ChitogenX fundamentals help investors to digest information that contributes to ChitogenX's financial success or failures. It also enables traders to predict the movement of ChitogenX OTC Stock. The fundamental analysis module provides a way to measure ChitogenX's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to ChitogenX otc stock.
ChitogenX |
ChitogenX OTC Stock Return On Equity Analysis
ChitogenX's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, ChitogenX has a Return On Equity of 0.0. This is 100.0% lower than that of the Healthcare sector and 100.0% lower than that of the Biotechnology industry. The return on equity for all United States stocks is 100.0% lower than that of the firm.
ChitogenX Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses ChitogenX's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of ChitogenX could also be used in its relative valuation, which is a method of valuing ChitogenX by comparing valuation metrics of similar companies.ChitogenX is currently under evaluation in return on equity category among its peers.
ChitogenX Fundamentals
| Return On Asset | -2.92 | |||
| Current Valuation | 12.49 M | |||
| Shares Outstanding | 51.04 M | |||
| Shares Owned By Insiders | 17.44 % | |||
| EBITDA | (3.72 M) | |||
| Net Income | (4.92 M) | |||
| Cash And Equivalents | 2.19 M | |||
| Cash Per Share | 0.04 X | |||
| Total Debt | 4.78 M | |||
| Current Ratio | 1.26 X | |||
| Book Value Per Share | (0.15) X | |||
| Cash Flow From Operations | (3.22 M) | |||
| Beta | 0.43 | |||
| Market Capitalization | 9.86 M | |||
| Total Asset | 1.12 M | |||
| Z Score | -8.7 | |||
| Net Asset | 1.12 M |
About ChitogenX Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze ChitogenX's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ChitogenX using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ChitogenX based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in ChitogenX OTC Stock
ChitogenX financial ratios help investors to determine whether ChitogenX OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in ChitogenX with respect to the benefits of owning ChitogenX security.